Healthcare >> CEO Interviews >> June 2, 2002

Christopher Henney – Dendreon Corporation (dndn)

CHRISTOPHER S. HENNEY joined Dendreon Corporation as Chief Executive Officer in May 1995. In 1989, Dr. Henney co-founded ICOS Corporation where from 1989 to 1995, he served as Executive Vice President, Scientific Director and Director. In 1981, Dr. Henney co-founded Immunex Corporation where from 1981 to 1989, he held various positions, including Director, Vice Chairman and Scientific Director. Prior to founding Immunex, Dr. Henney was an Academic Immunologist, serving as Professor at Johns Hopkins University and then the University of Washington where he also headed the immunology program at the Fred Hutchinson Cancer Research Center. Dr. Henney received a BSc with Honors, a PhD in Experimental Pathology and a DSc for his contributions to Immunology from the University of Birmingham, England. Profile
TWST: What is the current agenda at Dendreon?

Dr. Henney: Dendreon is an immunology company that is developing a

series of novel therapeutic vaccines and other immunological